ArticleFrontiers in endocrinology2015

Preclinical Effectiveness of Selective Inhibitor of IRS-1/2 NT157 in Osteosarcoma Cell Lines.

Cecilia Garofalo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.